{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:45:33Z","timestamp":1792194333333,"version":"4.4.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005318","name":"PICT","doi-asserted-by":"publisher","award":["1916"],"award-info":[{"award-number":["1916"]}],"id":[{"id":"10.13039\/100005318","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SANDOZ International GmbH, Business Unit Biopharmaceuticals"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ghir.2017.12.004","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T03:53:51Z","timestamp":1513050831000},"page":"19-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Genetic disorders of GH action pathway"],"prefix":"10.1016","volume":"38","author":[{"given":"Horacio M.","family":"Domen\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Fierro-Carri\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2017.12.004_bb0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0889-8529(05)70343-1","article-title":"The mechanisms by which growth hormone brings about growth. The relative contributions of growth hormone and insulin-like growth factors","volume":"25","author":"Spagnoli","year":"1996","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.ghir.2017.12.004_bb0010","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2005.07.028","article-title":"The role of the insulin-like growth factor system in prenatal growth","volume":"86","author":"Randhawa","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0015","series-title":"Modern Concepts in Insulin-like Growth Factors","first-page":"9","article-title":"The insulin-like growth factors and fetal growth","author":"D\u2019Ercole","year":"1991"},{"key":"10.1016\/j.ghir.2017.12.004_bb0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1210\/er.2010-0023","article-title":"Evidence for a continuum of genetic, phenotypic, and biochemical abnormalities in children with growth hormone insensitivity","volume":"32","author":"David","year":"2011","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2017.12.004_bb0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000342578","article-title":"Phenotypes, investigation and treatment of primary IGF-1 deficiency","volume":"24","author":"Savage","year":"2013","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.ghir.2017.12.004_bb0030","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1530\/EJE-15-0937","article-title":"Mechanisms in endocrinology: novel genetic causes of short stature","volume":"174","author":"Wit","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0035","first-page":"152","article-title":"Genetic pituitary dwarfism with high serum concentration of growth hormone \u2014 a new inborn error of metabolism?","volume":"2","author":"Laron","year":"1966","journal-title":"Israel J. Med. Sc."},{"key":"10.1016\/j.ghir.2017.12.004_bb0040","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1073\/pnas.86.20.8083","article-title":"Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism","volume":"86","author":"Godowski","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ghir.2017.12.004_bb0045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00442408","article-title":"Puberty in Laron type dwarfism","volume":"134","author":"Laron","year":"1980","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ghir.2017.12.004_bb0050","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199011153232002","article-title":"The little women of Loja \u2014 growth hormone-receptor deficiency in an inbred population of southern Ecuador","volume":"323","author":"Rosenbloom","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ghir.2015.08.001","article-title":"A half-century of studies of growth hormone insensitivity\/Laron syndrome: a historical perspective","volume":"28","author":"Rosenbloom","year":"2016","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2017.12.004_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2011.00095","article-title":"Genetic defects in the growth hormone-IGF-I axis causing growth hormone insensitivity and impaired linear growth","volume":"2","author":"Savage","year":"2011","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2017.12.004_bb0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/ng0597-13","article-title":"A dominant-negative mutation of the growth hormone receptor causes familial short stature (letter)","volume":"16","author":"Ayling","year":"1997","journal-title":"Nature Genetics"},{"key":"10.1016\/j.ghir.2017.12.004_bb0070","first-page":"531","article-title":"Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain","volume":"83","author":"Iida","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0075","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/js.2016-1119","article-title":"Novel dominant-negative GH receptor mutations expands the spectrum of GHI and IGF-I deficiency","volume":"1","author":"Vairamani","year":"2017","journal-title":"J. Endocr. Soc."},{"key":"10.1016\/j.ghir.2017.12.004_bb0080","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1086\/323266","article-title":"Exon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity","volume":"69","author":"Metherell","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ghir.2017.12.004_bb0085","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa022926","article-title":"Growth hormone insensitivity associated with a STAT5b mutation","volume":"349","author":"Kofoed","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0090","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1210\/jc.2006-0368","article-title":"Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation","volume":"91","author":"Vidarsdottir","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0095","doi-asserted-by":"crossref","first-page":"e1584","DOI":"10.1542\/peds.2005-2882","article-title":"Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation","volume":"118","author":"Bernasconi","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.ghir.2017.12.004_bb0100","series-title":"8th Joint Meeting of the Lawson Wilkins Pediatric Endocrine Society\/European Society for Paediatric Endocrinology","article-title":"Growth hormone insensitivity and immunodeficiency: mutation in the STAT5B gene","author":"Boyanovsky","year":"2009"},{"key":"10.1016\/j.ghir.2017.12.004_bb0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.beem.2010.09.003","article-title":"STAT5b deficiency: lessons from STAT5B gene mutations","volume":"25","author":"Hwa","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0110","doi-asserted-by":"crossref","first-page":"E830","DOI":"10.1210\/jc.2011-2554","article-title":"A novel missense mutation in the SH2 domain of the STAT5B gene results in a transcriptionally inactive STAT5b associated with severe IGF-I deficiency, immune dysfunction, and lack of pulmonary disease","volume":"97","author":"Scaglia","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ghir.2015.12.006","article-title":"STAT5B deficiency: impacts on human growth and immunity","volume":"28","author":"Hwa","year":"2016","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2017.12.004_bb0120","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/EJE-15-0398","article-title":"STAT5B mutations in heterozygous state have negative impact on height: another clue in human stature heritability","volume":"173","author":"Scalco","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0125","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ng.3040","article-title":"Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease","volume":"46","author":"Flanagan","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ghir.2017.12.004_bb0130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","article-title":"Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3","volume":"125","author":"Haapaniemi","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.ghir.2017.12.004_bb0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","article-title":"Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations","volume":"125","author":"Milner","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ghir.2017.12.004_bb0140","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1172\/JCI24228","article-title":"Knock your SOCS off!","volume":"115","author":"LeRoith","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2017.12.004_bb0145","unstructured":"P. Scaglia, A. Keselman, M. Guti\u00e9rrez, et al., Severe IGF-I deficiency and multi-organ autoimmune disease associated with novel STAT3 mutations, Horm. Res. Paediatr. 84 (suppl 1) (2015) 107 (Abstract)."},{"key":"10.1016\/j.ghir.2017.12.004_bb0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","article-title":"NF-kappa B: ten years after","volume":"87","author":"Baeuerle","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ghir.2017.12.004_bb0155","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1210\/jc.2009-1662","article-title":"Growth hormone and insulin-like growth factor I insensitivity of fibroblasts isolated from a patient with an I{kappa}B{alpha} mutation","volume":"95","author":"Wu","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM196601062740104","article-title":"Further observations on the Swiss type of agammaglobulinemia (alymphocytosis): the effect of syngeneic bone-marrow cells","volume":"274","author":"Rosen","year":"1966","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0165","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2249.2002.01823.x","article-title":"Atypical X-linked SCID phenotype associated with growth hormone hyporesponsiveness","volume":"129","author":"Ursini","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0170","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.4049\/jimmunol.177.10.6889","article-title":"Functional interaction of common gamma-chain and growth hormone receptor signaling apparatus","volume":"177","author":"Adriani","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0175","first-page":"46","article-title":"A selected miscellany","volume":"XI2","author":"Gorlin","year":"1975","journal-title":"Birth Defects Orig. Art. Ser."},{"key":"10.1016\/j.ghir.2017.12.004_bb0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajmg.1320150104","article-title":"Autosomal dominant partial lipodystrophy associated with Rieger anomaly, short stature, and insulinopenic diabetes","volume":"15","author":"Aarskog","year":"1983","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ghir.2017.12.004_bb0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1084\/jem.20112533","article-title":"Agammaglobulinemia and absent B lineage cells in a patient lacking the p85-alpha subunit of PI3K","volume":"209","author":"Conley","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ghir.2017.12.004_bb0195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/cge.12688","article-title":"Clinical reappraisal of SHORT syndrome with PIK3R1 mutations: towards recommendation for molecular testing and management","volume":"89","author":"Avila","year":"2016","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ghir.2017.12.004_bb0200","doi-asserted-by":"crossref","unstructured":"G. Alonso, D. Liberatore, A. Bernasconi, et al., Growth hormone insensitivity in a girl with hyper IgM-like syndrome due to mutation in PIK3R1, Horm. Res. Paediatr. 86 (suppl 2) (2016) Abstract. DOI: https:\/\/doi.org\/10.1159\/000451040.","DOI":"10.1159\/000451040"},{"key":"10.1016\/j.ghir.2017.12.004_bb0205","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJM199610313351805","article-title":"Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene","volume":"335","author":"Woods","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.beem.2010.08.005","article-title":"IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development","volume":"25","author":"Netchine","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0215","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1210\/jc.2004-1254","article-title":"Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation","volume":"90","author":"Walenkamp","year":"2005","journal-title":"J. Clin. Endocr. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000337249","article-title":"Identification of a novel heterozygous IGF1 splicing mutation in large kindred with familial short stature","volume":"78","author":"Fuqua","year":"2012","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2017.12.004_bb0225","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1210\/jc.2009-0452","article-title":"Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development","volume":"94","author":"Netchine","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000342841","article-title":"Molecular IGF-1 and IGF-1 receptor defects: from genetics to clinical management","volume":"24","author":"Walenkamp","year":"2013","journal-title":"Endocr. Dev."},{"key":"10.1016\/j.ghir.2017.12.004_bb0235","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJMoa1415227","article-title":"Paternally inherited IGF2 mutation and growth restriction","volume":"373","author":"Begemann","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0240","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/humu.23253","article-title":"De novo IGF2 mutation on the paternal allele in a patient with Silver-Russell syndrome and ectrodactyly","volume":"38","author":"Yamoto","year":"2017","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ghir.2017.12.004_bb0245","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fgene.2017.00105","article-title":"De novo mutation of paternal IGF2 gene causing Silver-Russell syndrome in a sporadic patient","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Genet."},{"key":"10.1016\/j.ghir.2017.12.004_bb0250","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa013100","article-title":"Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit gene","volume":"350","author":"Domen\u00e9","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1677\/joe.0.1700063","article-title":"The acid-labile subunit (ALS) of the 150kDa IGF-binding protein complex: an important but forgotten component of the circulating IGF system","volume":"170","author":"Boisclair","year":"2001","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0260","first-page":"129","article-title":"Human acid-labile subunit deficiency: clinical, endocrine, and metabolic consequences","volume":"72","author":"Domen\u00e9","year":"2009","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2017.12.004_bb0265","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/EJE-16-0999","article-title":"Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel IGFALS mutations","volume":"176","author":"I\u015f\u0131k","year":"2017","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0270","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/cen.13361","article-title":"Characterization of four Latin American families confirms previous findings and reveals novel features of acid-labile subunit deficiency","volume":"87","author":"Scaglia","year":"2017","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2017.12.004_bb0275","first-page":"339","article-title":"Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature","volume":"7","author":"Domen\u00e9","year":"2010","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.ghir.2017.12.004_bb0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.beem.2010.08.010","volume":"25","author":"Domen\u00e9","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0285","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000355412","article-title":"Heterozygous IGFALS gene variants in idiopathic short stature and normal children: impact on height and the IGF system","volume":"80","author":"Domen\u00e9","year":"2013","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2017.12.004_bb0290","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2016.03.031","article-title":"Assessment of pathogenicity of natural IGFALS gene variants by in silico bioinformatics tools and in vitro functional studies","volume":"429","author":"Martucci","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000355017","article-title":"Clinical features of a new acid-labile subunit (IGFALS) heterozygous mutation: anthropometric and biochemical characterization and response to growth hormone administration","volume":"81","author":"Grandone","year":"2014","journal-title":"Horm. Res. Paediatr."},{"issue":"Suppl","key":"10.1016\/j.ghir.2017.12.004_bb0300","first-page":"8","article-title":"El d\u00e9ficit de ALS en la talla baja idiop\u00e1tica","volume":"8","author":"Domen\u00e9","year":"2017","journal-title":"Rev. Esp. Endocrinol. Pediatr."},{"key":"10.1016\/j.ghir.2017.12.004_bb0305","doi-asserted-by":"crossref","unstructured":"A. Dauber A, M.T. Mu\u00f1oz-Calvo, V. Barrios, et al., Mutations in pregnancy-associated plasma protein A2 cause short stature due to low IGF-I availability, EMBO Mol. Med. 8 (2016) 363-374. doi: 10.15252\/emmm.201506106.","DOI":"10.15252\/emmm.201506106"},{"key":"10.1016\/j.ghir.2017.12.004_bb0310","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1210\/jc.2016-2751","article-title":"Treatment with recombinant human insulin-like growth factor-1 improves growth in patients with PAPP-A2 deficiency","volume":"101","author":"Mu\u00f1oz-Calvo","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0315","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa010107","article-title":"IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation","volume":"349","author":"Abuzzahab","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0320","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1210\/jc.2011-2142","article-title":"Severe short stature caused by novel compound heterozygous mutations of the insulin-like growth factor 1 receptor (IGF1R)","volume":"97","author":"P Fang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ghir.2017.12.004_bb0325","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-12-0701","article-title":"Homozygous mutation of the IGF1 receptor gene in a patient with severe pre- and postnatal growth failure and congenital malformations","volume":"168","author":"Gannag\u00e9-Yared","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ghir.2017.12.004_bb0330","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/humu.22853","article-title":"A new homozygous IGFr variant defines a clinically recognizable incomplete dominant form of SHORT syndrome","volume":"36","author":"Prontera","year":"2015","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ghir.2017.12.004_bb0335","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.beem.2010.09.012","article-title":"IGF1R mutations as cause of SGA","volume":"25","author":"Klammt","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0340","doi-asserted-by":"crossref","first-page":"E363","DOI":"10.1210\/jc.2010-0511","article-title":"Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 gene","volume":"95","author":"van Duyvenvoorde","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0345","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000464143","article-title":"Expanding genetic and functional diagnoses of IGF1R haploinsufficiencies","volume":"87","author":"Ocaranza","year":"2017","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2017.12.004_bb0350","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1210\/jc.2009-2404","article-title":"A heterozygous mutation of the insulin-like growth factor-I receptor causes retention of the nascent protein in the endoplasmic reticulum and results in intrauterine and postnatal growth retardation","volume":"95","author":"Wallborn","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0355","first-page":"113","article-title":"IGF1R mutation analysis in short children with Silver-Russell syndrome features","volume":"2","author":"Soellner","year":"2013","journal-title":"J. Pediatr. Genet."},{"key":"10.1016\/j.ghir.2017.12.004_bb0360","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/cen.12048","article-title":"Analysis of the insulin-like growth factor 1 receptor gene in children born small for gestational age: in vitro characterization of a novel mutation (p.Arg511Trp)","volume":"78","author":"Leal","year":"2013","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2017.12.004_bb0365","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/cen.12555","article-title":"Three novel IGF1R mutations in microcephalic patients with prenatal and postnatal growth impairment","volume":"82","author":"Juanes","year":"2015","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2017.12.004_bb0370","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/jpem-2014-0132","article-title":"Novel heterozygous IGF1R mutation in two brothers with developing impaired glucose tolerance","volume":"28","author":"Burkhardt","year":"2015","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1530\/EC-17-0038","article-title":"A novel heterozygous IGF-1 receptor mutation associated with hypoglycemia","volume":"6","author":"Solomon-Zemler","year":"2017","journal-title":"Endocr. Connect."},{"key":"10.1016\/j.ghir.2017.12.004_bb0380","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1516767","article-title":"Resolution of disease phenotypes resulting from multifocus genomic variation","volume":"376","author":"Posey","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2017.12.004_bb0385","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000338462","article-title":"Genetic analysis of short children with apparent growth hormone insensitivity","volume":"77","author":"Wit","year":"2012","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.ghir.2017.12.004_bb0390","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1210\/jc.2014-1506","article-title":"Genetic evaluation of short stature","volume":"99","author":"Dauber","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2017.12.004_bb0395","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-17-0453","article-title":"Whole exome sequencing gives additional benefits compared to candidate gene sequencing in the molecular diagnosis of children with growth hormone or IGF-1 insensitivity","volume":"177","author":"Shapiro","year":"2017","journal-title":"Eur. J. Endocrinol."}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417301132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637417301132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:14Z","timestamp":1761087074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637417301132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":79,"alternative-id":["S1096637417301132"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2017.12.004","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic disorders of GH action pathway","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2017.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}